Optibrium

Optibrium introduces StarDrop 6.5

Optibrium, a developer of software for drug discovery, has announced the launch of version 6.5 of StarDrop software. Stardrop provides a complete platform for small molecule design, optimisation and data analysis

Synergy between man and machine

The failure of a candidate drug can cost millions – so many chemists are turning to software that provides modelling capabilities and multi-parameter optimisation

Optibrium Expands US and UK Operations

Optibrium, a developer of software for small molecule drug discovery, today announced it has appointed Dr Scott Lyon as director of business development and relocated its Headquarters and research facilities, to Cambridge Innovation Park, Cambridge, UK

Optibrium Joins the eTRANSAFE project

A new collaboration featuring a prestigious line-up of pharma companies, academic organisations and SMEs are aiming to improve the security in the drug development process

Bugworks license Optibrium's StarDrop software

Optibrium and Bugworks Research, a company focused on discovering biopharmaceuticals for the treatment of critical and serious bacterial infections, have announced the signing of a two-year agreement to license Optibrium’s StarDrop software

Optibrium and Goldfinch agree to StarDrop license

Optibrium, a developer of software for small molecule discovery, and Goldfinch Bio, a company focused on discovering and developing precision therapies to treat patients with kidney disease, today announced that the company has signed a multi-year agreement to license Optibrium’s StarDrop software

Pages

Subscribe to RSS - Optibrium